LIPOPROTEINS CONTAINING APOLIPOPROTEIN A-IV - COMPOSITION AND RELATION TO CHOLESTEROL ESTERIFICATION

被引:15
|
作者
DUVERGER, N [1 ]
GHALIM, N [1 ]
THERET, N [1 ]
FRUCHART, JC [1 ]
CASTRO, G [1 ]
机构
[1] INST PASTEUR, INSERM, U325, F-59019 LILLE, FRANCE
来源
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM | 1994年 / 1211卷 / 01期
关键词
LIPOPROTEIN; APO A-I; APO A-II; APO A-IV; LCAT; CHOLESTEROL ESTERIFICATION; SPHINGOMYELIN; PHOSPHATIDYLCHOLINE; FATTY ACID COMPOSITION;
D O I
10.1016/0005-2760(94)90134-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In order to investigate the relationship of lipid and apolipoprotein composition to cholesterol esterification in lipoproteins containing apolipoprotein (ape) A-IV, apo A-containing lipoprotein particles were isolated from fresh human plasma using a system of sequential immunoaffinity chromatography. Plasma was first depleted of apo B- and apo E-containing lipoproteins. Four major subpopulations of ape A-containing lipoprotein particles were separated: Lp A-I, Lp A-I:A-II, Lp A-IV and Lp A-I:A-IV:A-II. Lp A-IV and Lp A-I:A-IV:A-II contained less total lipid, less cholesterol and more triacylglycerol than Lp A-I and Lp A-I:A-II. Lp A-IV and Lp A-I:A-IV:A-II contained more sphingomyelin and less phosphatidylcholine than Lp A-I and Lp A-I:A-II and were richer in (16:0 +/- 18:0) saturated fatty acids. Among these isolated lipoprotein particles, Lp A-IV contained the highest lecithin: cholesterol acyltransferase (LCAT) activity per mu g of protein. Cholesterol esterification rates were 2.6 +/- 0.5, 5.3 +/- 0.4 and 0.8 +/- 0.2 mu mol of cholesterol per hour per m,a of lipoproteins for Lp A-IV, Lp A-I and Lp A-I:A-II, respectively. The apolipoprotein and lipid composition and LCAT activity of Lp A-IV suggest that this lipoprotein may be a source of cholesterol esterification in plasma.
引用
收藏
页码:23 / 28
页数:6
相关论文
共 50 条
  • [21] Rates of cholesterol esterification and esterified cholesterol net mass transfer between high-density lipoproteins and apolipoprotein B-containing lipoproteins in Type 1 diabetes
    Valabhji, J
    Donovan, J
    McColl, AJ
    Schachtert, M
    Richmond, W
    Elkeles, RS
    DIABETIC MEDICINE, 2002, 19 (05) : 424 - 428
  • [22] Role of apolipoprotein A-IV and its polymorphisms for reverse cholesterol transport and coronary risk
    VonEckardstein, A
    Assmann, G
    NUTRITION, GENETICS, AND HEART DISEASE, 1996, 6 : 198 - 211
  • [23] CIRCADIAN-RHYTHM OF SERUM APOLIPOPROTEIN A-IV (APO A-IV) OF RATS
    FUKAGAWA, K
    GOU, HM
    TSO, P
    GASTROENTEROLOGY, 1993, 104 (04) : A622 - A622
  • [24] Effects of a National Cholesterol Education Program Step II Diet on apolipoprotein A-IV metabolism within triacylglycerol-rich lipoproteins and plasma
    Sun, ZY
    Welty, FK
    Dolnikowski, GG
    Lichtenstein, AH
    Schaefer, EJ
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2001, 74 (03): : 308 - 314
  • [25] Plaque stabilizing effects of apolipoprotein A-IV
    Geronimo, F. R. B.
    Barter, P. J.
    Rye, K. A.
    Heather, A. K.
    Shearston, K. D.
    Rodgers, K. J.
    ATHEROSCLEROSIS, 2016, 251 : 39 - 46
  • [26] HUMAN APOLIPOPROTEIN A-IV - INTESTINAL ORIGIN
    GREEN, PHR
    GLICKMAN, RM
    RILEY, JW
    QUINET, E
    GASTROENTEROLOGY, 1979, 76 (05) : 1143 - 1143
  • [27] Apolipoprotein A-IV Associated Cardiac Amyloidosis
    Bois, Melanie C.
    Dasari, Surendra
    Theis, Jason D.
    Vrana, Julie
    Grogan, Martha
    Dispenzieri, Angela
    Kurtin, Paul J.
    Maleszewski, Joseph J.
    MODERN PATHOLOGY, 2016, 29 : 81A - 82A
  • [28] Apolipoprotein A-IV, food intake, and obesity
    Tso, P
    Liu, M
    PHYSIOLOGY & BEHAVIOR, 2004, 83 (04) : 631 - 643
  • [29] Regulation of intestinal apolipoprotein A-IV synthesis
    Tso, P
    Yao, L
    Zheng, S
    Ee, L
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1998, 13 : S270 - S274
  • [30] Regulation of intestinal and hypothalamic apolipoprotein A-IV
    Liu, M
    Doi, T
    Tso, P
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2003, 228 (10) : 1181 - 1189